Tang Capital Management as of Sept. 30, 2014
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 12 positions in its portfolio as reported in the September 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Salix Pharmaceuticals | 24.3 | $47M | 300k | 156.24 | |
| Heron Therapeutics (HRTX) | 21.2 | $41M | 4.9M | 8.33 | |
| Pdl Biopharma Inc cnv | 19.4 | $37M | 26M | 1.44 | |
| OPK CB 3 01FEB2033 144A BOND 01feb2033 | 9.7 | $19M | 14M | 1.34 | |
| La Jolla Pharmaceuticl Com Par | 9.5 | $18M | 1.9M | 9.61 | |
| BioMarin Pharmaceutical (BMRN) | 6.8 | $13M | 182k | 72.16 | |
| Merrimack Pharmaceuticals In note 4.500% 7/1 | 4.4 | $8.5M | 5.5M | 1.54 | |
| Mirati Therapeutics | 2.6 | $5.1M | 288k | 17.51 | |
| Horizon Pharma | 1.9 | $3.7M | 300k | 12.28 | |
| Rxi Pharmaceuticals | 0.1 | $100k | 50k | 1.99 | |
| Dendreon Corporation | 0.0 | $80k | 56k | 1.44 | |
| Ambit Bioscience | 0.0 | $0 | 46.00 | 0.00 |
